Why stopping antidepressants is harder than most people expect
Antidepressants — particularly SSRIs and SNRIs — cause long-term changes to the way the brain regulates serotonin and other neurotransmitters. After months or years of use, the nervous system adapts around the medication. When the medication is removed, the brain needs time to readjust.
This process is often more prolonged and more uncomfortable than patients are warned about. Around half of people experience withdrawal symptoms when stopping antidepressants, and for a significant proportion those symptoms can be severe and long-lasting — particularly for people who have been on medication for several years.
The problem is not usually the person. It is almost always the pace.
What are antidepressant withdrawal symptoms?
Withdrawal symptoms arise because the nervous system is adjusting to the absence of medication it has come to rely on. They are not a sign of weakness, addiction in the traditional sense, or relapse of the original condition — though they are frequently mistaken for relapse.
Common withdrawal symptoms include:
- Physical: dizziness, nausea, flu-like sensations, sweating, headaches, electric shock sensations in the head or body (often called "brain zaps"), tremor
- Sleep: vivid dreams, insomnia, disrupted sleep cycles
- Sensory: heightened sensitivity to light, sound and temperature
- Emotional: anxiety, irritability, low mood, emotional blunting or emotional flooding, difficulty concentrating
- Cognitive: memory difficulties, brain fog, confusion
For most people these symptoms are temporary and settle with careful pacing. For some — particularly those who have been on higher doses for longer periods — they can persist for months or, in a small number of cases, longer.
Which antidepressants are hardest to stop?
All antidepressants require careful management when stopping, but some are more challenging than others, largely because of how long they stay in the body (their half-life) and how they interact with receptors.
| Medication | Brand | Difficulty | Key considerations |
|---|---|---|---|
| Venlafaxine | Efexor | High | Very short half-life; withdrawal can begin within hours of a missed dose |
| Paroxetine | Seroxat | High | Short half-life; well-documented withdrawal profile; often requires very slow taper |
| Duloxetine | Cymbalta | High | Short half-life; symptoms can be intense; liquid formulation helpful for slow taper |
| Sertraline | Lustral / Zoloft | Moderate | Most-prescribed in UK; manageable with careful tapering; widely available in liquid form |
| Citalopram / Escitalopram | Cipramil / Cipralex | Moderate | Longer half-life than paroxetine; liquid formulation available |
| Fluoxetine | Prozac | Lower | Very long half-life (weeks); self-tapering to a degree; lowest withdrawal risk of common SSRIs |
| Mirtazapine | Zispin | Mod–High | Often prescribed for sleep; stopping can severely disrupt sleep; requires careful planning |
What does safe tapering actually look like?
Current NICE guidance and the Royal College of Psychiatrists recommend hyperbolic tapering — a pattern of reduction that gets proportionally smaller as the dose gets lower. This matters because the relationship between dose and effect on the brain is not linear. Small doses at the low end have disproportionately large effects on the nervous system.
In practice, this means:
- Reductions are made as a proportion of the current dose — not by a fixed amount each time
- The pace slows considerably as lower doses are reached
- The last few milligrams often take longer to reduce than the preceding months
- Liquid formulations are frequently necessary to achieve very small, precise reductions
- The timeline is guided by how the person is responding — not by a fixed calendar
For someone who has been on an antidepressant for five or more years, safe reduction may realistically take twelve to twenty-four months or more. This is not unusual, and attempting to do it faster frequently leads to distressing withdrawal and eventual reinstatement.
Key principles of safe antidepressant reduction
- Reduce proportionally — each step is a percentage of the current dose, not a fixed amount
- Slow down at lower doses — the final stages often take the longest
- Pause, do not push through — if symptoms are significant, hold the dose until they settle
- Liquid formulations allow very small, precise reductions when tablets are no longer granular enough
- Never stop abruptly after prolonged use — the nervous system needs time to readjust
- Distinguish withdrawal symptoms from relapse — they look similar but require very different responses
Withdrawal or relapse — how to tell the difference
One of the most distressing aspects of stopping antidepressants is that withdrawal symptoms can closely resemble the original condition for which the medication was prescribed. Anxiety, low mood, difficulty sleeping and difficulty concentrating are common to both. Misidentifying withdrawal as relapse leads to medication being reinstated when it does not need to be.
The key distinguishing features:
- Timing: withdrawal symptoms typically begin within days to a week of a dose reduction; relapse of depression usually develops more gradually over weeks
- Physical symptoms: dizziness, brain zaps and flu-like sensations are characteristic of withdrawal — not typical features of depression relapse
- Familiarity: relapse symptoms tend to resemble the original presentation; withdrawal symptoms are often experienced as new or different
- Response to dose: reinstating or slightly increasing the dose resolves withdrawal symptoms quickly; it does not resolve a genuine relapse at the same speed
For a detailed clinical discussion of this distinction, see our guide: Withdrawal or relapse — understanding the difference.
Who we can help
Our deprescribing service is appropriate for adults who:
- Want to reduce or stop a long-term antidepressant with proper clinical oversight
- Have tried to stop before and found it very difficult
- Have been told by their GP that reduction is straightforward, but are finding it anything but
- Are experiencing side effects — emotional blunting, sexual dysfunction, weight gain, cognitive effects — and want to explore whether medication is still appropriate
- Are questioning whether they still need the medication they were prescribed years ago
This is not a crisis service
Our deprescribing service is for people who are broadly stable and want to reduce medication safely and gradually. If you are in acute distress or having thoughts of suicide or self-harm, please contact your GP, call 111, or call Samaritans on 116 123. We are not an emergency service and cannot provide crisis support.
Clinical summary for GPs
We offer consultant-led, outpatient deprescribing support for patients wishing to reduce long-term antidepressants. We provide a full psychiatric assessment, a bespoke hyperbolic taper plan, and regular monitoring throughout. We will communicate with the patient's GP at each significant stage and can issue private prescriptions where required during the taper. Referral by letter is helpful but not essential — patients can self-refer.
Relevant guidance
- NICE guideline on depression in adults (NG222) — section on stopping antidepressants
- NICE guideline on medicines associated with dependence or withdrawal symptoms (NG215)
- Royal College of Psychiatrists: Stopping Antidepressants (2021, updated guidance)
- Maudsley Deprescribing Guidelines (2024)